Treatment Of Diffuse Conjunctival Lymphangiectasia With The Panis Method: A Case Study

Conjunctival lymphangiectasia explained rare condition, when ocular lymphatic vessels dilated and usually treated by invasive surgeries. This research evaluated noninvasive plasma-based therapy for lymphangiectasia ablation.

A 31-year-old male have been visited and diagnosed with conjunctival lymphangiectasia in his right eye and he underwent plasma assisted noninvasive surgery (PANIS) for treatment. 

Before the PANIS procedure, he checked by uncorrected visual acuity (UCVA), refractive error, best-corrected visual acuity (BCVA), intraocular pressure (IOP), and anterior segment optical coherence tomography (AS-OCT), ocular surface disease questionnaire (OSDI) and slit-lamp examination and all these parameters have been measured 1 month and 6 month after surgery. With using white handpiece (0.7 watt) of PLEXR PLUS device, plasma as the ionized gas spotted on the pathology on the ocular surface under local anesthesia in office. The post operation medication was antibiotic eye drop for 1 week and corticosteroid tapered in 4 weeks. 

The treated eye showed no complication or any pain during and after the surgery. No signs of recurrence and inflammation indicated. The slit-lamp examination and AS-OCT proved the treatment was successful. As we expected, visual parameters has not changed in the follow-up period. Patient's satisfaction has been obtained by elimination of foreign body sensation and tearing symptoms. The mean difference value of OSDI is 44.76.

It seems that PANIS is a safe and office-based method for managing signs and symptoms of this resistant ocular disease, considering this successful outcome after PANIS intervention.